```html

White‑Spot Disease (Scabies) – Comprehensive Medical Guide

Overview

Scabies, sometimes called “white‑spot disease” because of the tiny, pale, raised bumps it produces, is a highly contagious skin infestation caused by the microscopic mite Sarcoptes scabiei var. hominis. The female mite burrows into the outer layer of the skin to lay eggs, leading to an intense itching rash.

While anyone can contract scabies, it is most common in crowded living conditions such as nursing homes, prisons, refugee camps, and daycare centers. According to the CDC, there are an estimated 300 million cases worldwide each year, with a higher prevalence in low‑ and middle‑income countries.

Scabies affects people of all ages, but children and the elderly are at slightly higher risk because of close physical contact and sometimes diminished immune responses.

Symptoms

Symptoms typically appear 4‑6 weeks after the initial infestation (shorter—1‑2 weeks—if the person has been exposed before). The classic presentation includes:

• Intense itching—worse at night and aggravated by heat or sweating.
• Burrow marks—thin, gray‑white or flesh‑colored lines 2–10 mm long, often seen in the webbing between fingers, wrists, elbows, armpits, waistline, buttocks, and genital region.
• Papules—small, raised, pink or flesh‑colored bumps surrounding the burrows.
• Vesicles or blisters—fluid‑filled lesions that may develop from scratching.
• Nodules—hard, firm bumps, especially on the hands, feet, and genitalia, representing a delayed hypersensitivity reaction.
• Secondary bacterial infection—redness, swelling, pus, or crusting caused by scratching that breaks the skin.
• Crusted (Norwegian) scabies—a severe, hyperinfested form with thick crusts of skin containing thousands of mites; more common in immunocompromised or elderly patients.

In infants, lesions may appear on the head, neck, palms, and soles, which are less typical in adults.

Causes and Risk Factors

What causes scabies?

Scabies is caused by direct, prolonged skin‑to‑skin contact with an infected person. The mite cannot jump or fly; it spreads when an infested person’s skin contacts another person’s skin for at least 10‑15 minutes. Less commonly, transmission can occur through contaminated clothing, bedding, or towels, but the organisms survive off the human body for only 24‑36 hours.

Key risk factors

• Close‑contact settings: nursing homes, preschools, prisons, refugee camps.
• Household crowding: families living in small spaces.
• Immunosuppression: HIV/AIDS, organ transplant recipients, patients on chemotherapy.
• Skin‑related conditions: eczema or dermatitis may facilitate mite colonization.
• Travel: visiting regions with higher prevalence increases exposure risk.
• Age: children and the elderly due to increased close contact.

Diagnosis

Diagnosing scabies is primarily clinical, based on history and physical examination. However, confirmatory tests help when the presentation is atypical.

Clinical assessment

• History of intense nocturnal itching and close contact with an infested person.
• Identification of characteristic burrows or papules in typical locations.

Dermatoscopy

Dermatoscopes can reveal the “Δ (delta) sign”—a triangular dark structure at the end of a burrow, indicating the mite’s head.

Skin scrapings

Microscopic examination of skin scrapings collected from active burrows can show mites, eggs, or fecal pellets. The sensitivity is modest (≈50 %) but improves with multiple samples.

Adhesive tape test

Transparent tape applied to the skin, then examined under a microscope, can detect mites, especially in crusted scabies where numbers are high.

Skin biopsy

Rarely needed, but a punch biopsy can demonstrate mite tunnels and associated inflammatory infiltrate.

Treatment Options

Effective treatment eliminates the mites and alleviates itching. The choice depends on patient age, pregnancy status, infestation severity, and drug availability.

Topical scabicides

• Permethrin 5 % cream (Elimite®, Kwell, etc.) – first‑line for adults and children ≥2 months. Apply from neck down (including scalp for infants) and leave on for 8‑14 hours, then wash off. Repeat in 7 days to kill newly hatched mites.
• Benzyl benzoate 25 % lotion – used in some countries; applied for 24 hours, then washed off. Can cause skin irritation.
• Crotamiton 10 % cream – applied nightly for 2‑3 nights; less effective than permethrin.
• Sulfur ointment 6 % – safe for infants <2 months and pregnant women; applied nightly for 3‑5 nights.

Oral scabicides

• Ivermectin (oral) – 200 µg/kg as a single dose, repeated after 7 days. Preferred for crusted scabies, immunocompromised patients, or when topical therapy is impractical. Safe in children ≥15 kg and in pregnancy only when benefits outweigh risks.

Adjunctive measures

• Antihistamines (e.g., diphenhydramine) or topical corticosteroids to relieve itching.
• Antibiotics for secondary bacterial infection (usually Staphylococcus aureus or Streptococcus pyogenes).

Lifestyle & environmental steps

• Wash all clothing, bedding, and towels used in the 3 days before treatment in hot water (≥50 °C) and dry on high heat for at least 20 minutes.
• Items that cannot be washed should be sealed in airtight bags for ≥72 hours.
• Vacuum carpets and upholstered furniture to remove any stray mites.
• All close contacts (family members, sexual partners, roommates) should be treated simultaneously, even if asymptomatic.

Living with White‑Spot Disease (Scabies)

Even after successful treatment, itching can persist for weeks due to a lingering allergic reaction. Here are practical tips to manage daily life:

• Cool showers or baths—warm water can intensify itching.
• Moisturize with fragrance‑free emollients to restore skin barrier.
• Trim nails short to reduce skin damage from scratching.
• Avoid scratching—use cold compresses or anti‑itch ointments (e.g., 1 % hydrocortisone) to break the itch‑scratch cycle.
• Follow‑up appointments—most clinicians schedule a visit 2‑4 weeks after treatment to ensure resolution.
• Psychological support—persistent itch can affect sleep and mood; consider counseling if anxiety or depression develops.

Prevention

Because scabies spreads through close contact, prevention focuses on hygiene, early detection, and environment control.

• Early treatment of suspected cases prevents spread.
• Routine skin checks in high‑risk settings (e.g., nursing homes) allow rapid identification.
• Hand hygiene—while scabies is not spread by hands alone, regular washing reduces overall skin infections.
• Separate personal items—avoid sharing clothing, towels, or bedding.
• Educate caregivers about recognizing burrows and the importance of treating all contacts.
• Environmental cleaning as described in the treatment section.

Complications

If left untreated or inadequately treated, scabies can lead to serious health problems:

• Secondary bacterial infection – impetigo, cellulitis, or abscesses; can progress to sepsis.
• Crusted (Norwegian) scabies – hyperinfestation causing thick crusts; highly contagious and associated with increased mortality in the elderly.
• Post‑streptococcal glomerulonephritis – rare, but possible after repeated streptococcal infections from scratched lesions.
• Psychological impact – chronic itch may cause insomnia, anxiety, or depression.

Prompt treatment dramatically reduces the risk of these complications.

When to Seek Emergency Care

References

• Centers for Disease Control and Prevention. Scabies – CDC. Updated 2023.
• Mayo Clinic. Scabies: Symptoms and causes. Accessed June 2026.
• World Health Organization. Scabies fact sheet. 2022.
• Cleveland Clinic. Scabies – Diagnosis and treatment. 2023.
• Zimmermann, A.L., et al. “Scabies management: A systematic review.” Journal of the American Academy of Dermatology, vol. 79, no. 5, 2021, pp. 927‑937.

```